Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 31, Issue 5, Pages 668-675
Publisher
Wiley
Online
2015-10-14
DOI
10.1002/mds.26422
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis
- (2014) Gennaro Pagano et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
- (2013) David J. Irwin et al. NATURE REVIEWS NEUROSCIENCE
- The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related Dementia
- (2013) Yaroslau Compta et al. Neurodegenerative Diseases
- Neuropathology of dementia in a large cohort of patients with Parkinson's disease
- (2013) Judit Horvath et al. PARKINSONISM & RELATED DISORDERS
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia
- (2012) Paul T. Kotzbauer et al. ARCHIVES OF NEUROLOGY
- Cerebrospinal fluid amyloid- and phenotypic heterogeneity in de novo Parkinson's disease
- (2012) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- APOE ϵ4 Increases Risk for Dementia in Pure Synucleinopathies
- (2012) Debby Tsuang et al. JAMA Neurology
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
- (2011) Y. Compta et al. BRAIN
- A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies
- (2011) T. Lashley et al. BRAIN
- Does levodopa accelerate the pathologic process in Parkinson disease brain?
- (2011) L. Parkkinen et al. NEUROLOGY
- Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation
- (2010) Eri Himeno et al. ANNALS OF NEUROLOGY
- Synergistic Interactions between A , Tau, and -Synuclein: Acceleration of Neuropathology and Cognitive Decline
- (2010) L. K. Clinton et al. JOURNAL OF NEUROSCIENCE
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- A clinico-pathological study of subtypes in Parkinson's disease
- (2009) M. Selikhova et al. BRAIN
- Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
- (2008) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients
- (2008) Tammaryn Lashley et al. ACTA NEUROPATHOLOGICA
- Unknown
- (2008) G Irvine et al. MOLECULAR MEDICINE
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Dementia and survival in Parkinson disease: A 12-year population study
- (2008) T. C. Buter et al. NEUROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started